Who owns Intellia Therapeutics Inc (NTLA)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Intellia Therapeutics Inc (NTLA) in their latest 13F filing, with $284.4M between them. Cathie Wood gives it the most weight: 1.11% of the reported portfolio. In their latest reported quarter, Peter Kolchinsky and Julian and Felix Baker opened a position; Cathie Wood reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Cathie Wood, $192.1M
- Largest weight
- Cathie Wood, 1.11%of their portfolio
- Combined value
- $284.4M
- Bought last quarter
- 2
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Cathie WoodARK Invest | 1.11% | $192.1M | 15.93M | ▼ Reduced 5.6% | −950.08K | Q3 2026 |
| 2 | Peter KolchinskyRA Capital Management | 0.67% | $76.6M | 4.53M | New | +4.53M | Q2 2026 |
| 3 | Julian and Felix BakerBaker Bros. Advisors | 0.08% | $15.7M | 930.23K | New | +930.23K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 15.93M | $192.1M | 0 | 1 |
| Q2 2026 | 157 | 3 | 22.33M | $377.9M | 3 | 0 |
| Q1 2026 | 157 | 1 | 14.51M | $186M | 1 | 0 |
| Q4 2025 | 157 | 1 | 14.21M | $127.7M | 1 | 3 |
| Q3 2025 | 157 | 4 | 15.64M | $270.1M | 3 | 1 |
| Q2 2025 | 157 | 2 | 15.69M | $147.2M | 2 | 0 |
| Q1 2025 | 156 | 2 | 13.66M | $97.1M | 1 | 1 |
| Q4 2024 | 156 | 3 | 13.46M | $156.9M | 2 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 15.93M | 16.88M | 14.51M | 14.21M | 11.92M | 13.02M | 13.01M | 12.54M |
| Peter Kolchinsky | · | 4.53M | — | — | — | — | — | — |
| Julian and Felix Baker | · | 930.23K | — | — | 2.75M | 2.68M | 644.12K | 644.12K |
| Andrew Spokes | — | — | — | — | 607.2K | — | — | — |
| Robert Pitts | · | — | — | — | 365.4K | — | — | — |
| Temasek | — | — | — | — | — | — | — | 279.69K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own NTLA?
In their latest 13F filings: Cathie Wood (1.11% of the portfolio, $192.1M), Peter Kolchinsky (0.67% of the portfolio, $76.6M), Julian and Felix Baker (0.08% of the portfolio, $15.7M).
Who bought NTLA last quarter?
Peter Kolchinsky (new position), Julian and Felix Baker (new position). “Last quarter” is each investor's latest reported quarter.
Who sold NTLA last quarter?
Reduced: Cathie Wood (5.6% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Intellia Therapeutics Inc (NTLA)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/NTLA/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to NTLA by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.